David Chernow - Select Medical President, Chief Executive Officer
| SEM Stock | USD 21.11 0.76 3.73% |
CEO
Mr. David S. Chernow is President, Chief Executive Officer of the Company. Mr. Chernow has served as our President and previously held various executive officer titles since September 2010. Mr. Chernow served as a director of the Company from January 2002 until February 2005 and from August 2005 until September 2010. Mr. Chernow also serves on the board of directors of Concentra Group Holdings Parent. From May 2007 to February 2010, Mr. Chernow served as the President and Chief Executive Officer of Oncure Medical Corporationration, one of the largest providers of freestanding radiation oncology care in the United States. From July 2001 to June 2007, Mr. Chernow served as the President and Chief Executive Officer of JA Worldwide, a nonprofit organization dedicated to the education of young people about business . From 1999 to 2001, he was the President of the Physician Services Group at US Oncology, Inc. Mr. Chernow cofounded American Oncology Resources in 1992 and served as its Chief Development Officer until the time of the merger with Physician Reliance Network, Inc., which created US Oncology, Inc. in 1999. since 2014.
| Age | 67 |
| Tenure | 10 years |
| Address | 4714 Gettysburg Road, Mechanicsburg, PA, United States, 17055 |
| Phone | 717 972 1100 |
| Web | https://www.selectmedical.com |
Select Medical Management Efficiency
The company has Return on Asset of 0.0484 % which means that on every $100 spent on assets, it made $0.0484 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1842 %, implying that it generated $0.1842 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 29th of November 2024, Return On Equity is likely to grow to 0.20, while Return On Tangible Assets are likely to drop 0.06. At this time, Select Medical's Asset Turnover is very stable compared to the past year.Similar Executives
| Found 10 records | CEO Age | ||
| James MD | Mednax Inc | 62 | |
| Stephen Flatt | National HealthCare | 68 | |
| Christopher Christensen | The Ensign Group | 55 | |
| Mark Ordan | Mednax Inc | 65 | |
| Roger Medel | Mednax Inc | 74 | |
| April Anthony | Encompass Health Corp | 53 | |
| Dirk Allison | Addus HomeCare | 68 | |
| Patrick Blair | InnovAge Holding Corp | 53 | |
| Mark Tarr | Encompass Health Corp | 62 | |
| Dirk CPA | Addus HomeCare | 68 | |
Management Performance
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0484 |
Select Medical Holdings Leadership Team
Elected by the shareholders, the Select Medical's board of directors comprises two types of representatives: Select Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Select. The board's role is to monitor Select Medical's management team and ensure that shareholders' interests are well served. Select Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Select Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Saich, Executive Vice President Chief Human Resources Officer | ||
| Bridget Sherick, Senior Services | ||
| James Ely, Independent Director | ||
| Michael Malatesta, Executive CFO | ||
| Russell Carson, Lead Independent Director | ||
| Bryan Cressey, Independent Director | ||
| Thomas Scully, Independent Director | ||
| William Frist, Independent Director | ||
| Martin Jackson, Chief Financial Officer, Executive Vice President | ||
| Thomas Mullin, Executive Vice President - Hospital Operations | ||
| Katherine Davisson, Independent Director | ||
| Shelly Eckenroth, Marketing Communications | ||
| David Chernow, President, Chief Executive Officer | ||
| Christopher Weigl, Controller VP | ||
| Robert Breighner, Vice President, Compliance and Audit Services and Corporate Compliance Officer | ||
| Parvinderjit Khanuja, Independent Director | ||
| Michael Tarvin, Executive Vice President General Counsel, Secretary | ||
| John Duggan, Executive Counsel | ||
| Rocco Ortenzio, Vice Chairman of the Board, Co-Founder | ||
| Daniel Thomas, Independent Director | ||
| Mary Lacey, Senior Officer | ||
| Scott Romberger, Senior Vice President, Chief Accounting Officer, Controller | ||
| Robert Ortenzio, Executive Chairman of the Board, Co-Founder | ||
| Brian Rusignuolo, Executive Officer | ||
| Joel Veit, VP Treasurer | ||
| Marilyn Tavenner, Independent Director |
Select Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Select Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0484 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 7 B | ||||
| Shares Outstanding | 128.99 M | ||||
| Shares Owned By Insiders | 17.32 % | ||||
| Shares Owned By Institutions | 78.97 % | ||||
| Number Of Shares Shorted | 1.79 M | ||||
| Price To Earning | 13.33 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.139 | Dividend Share 0.5 | Earnings Share 2.14 | Revenue Per Share 56.158 | Quarterly Revenue Growth 0.057 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.